|
NIG-RNAi Strains Detail |
Request : Click the "Order" button to request for this stock |
|
Stock Detail (Last Update: November 2007_FlyBase version FB2007_11) |
Stock ID |
11062R-1 |
Symbol |
activin-beta |
Full Name |
activin-beta |
CG No |
CG11062 |
Old CG No |
CG11062 |
Synonyms |
Activin, dact, dAct, dACT, CG11062, anon-WO02059370.79, activin-beta, beta-Activin |
Accession No (Link to NCBI) |
NM_143685.2 |
Inserted Chr. |
lll |
Insertional Mutation |
|
Phenotype induced by Act5C-GAL4 at 28 degrees |
viable |
Map Viewer |
|
Reference
[Please submit your publication]
|
Graca FA, Rai M, Hunt LC, Stephan A, Wang YD, Gordon B, Wang R, Quarato G, Xu B, Fan Y, Labelle M, Demontis F. The myokine Fibcd1 is an endogenous determinant of myofiber size and mitigates cancer-induced myofiber atrophy. Nat Commun (2022) 13(1) 2370
[
PubMed ID = 35501350
]
[
RRC reference
]
Eusebio N, Tavares L, Pereira PS. CtBP represses Dpp-dependent Mad activation during Drosophila eye development. Dev Biol (2018) 442(1) 188-198
[
PubMed ID = 30031756
]
[
RRC reference
]
Song W, Cheng D, Hong S, Sappe B, Hu Y, Wei N, Zhu C, O'Connor MB, Pissios P, Perrimon N. Midgut-Derived Activin Regulates Glucagon-like Action in the Fat Body and Glycemic Control. Cell Metab (2017) 25(2) 386-399
[
PubMed ID = 28178568
]
[
RRC reference
]
Hevia CF, de Celis JF. Activation and function of TGFβ signalling during Drosophila wing development and its interactions with the BMP pathway. Dev Biol (2013) 377(1) 138-53
[
PubMed ID = 23485686
]
[
RRC reference
]
|
Comment |
|
Sequence (Last Update: July 10, 2007_NCBI RefSeq Release 24) |
Primer Seq. 5' |
aaggcctacatggccggaccgCATTCAAAGGCAGCAGGTGTT |
Primer Seq. 3' |
aatctagaggtaccCTGTCGTTTACGATTGCGACT |
Predicted Fragment Size |
500 |
IR fragment full Seq |
0001 CATTCAAAGG CAGCAGGTGT TTCTTTAATT GTCAATGCAT CTGCTGTCGC CAAGGATGCT
0061 GCGTTGTGGT TGTAAAGTGC TGTTGCTGCT TTAACTTAAA CTGCTGCAAC AGCCTTGGCT
0121 CCCGGAAGTC ATTTCCACAA CCCGCTGCAA TGCGTAAAAA AGTTGCTGAC CTCGAAGTCC
0181 TTAGAGTATC AAGGTTTGTG GCGGTTATTT TAGTGCTGGC TCGGTGGGTT ACTGCGGTAG
0241 CGACACTCCT GACAAGCTGC ATACTCCTAG ACATATTTTC CGTGCCTGGC CAGTCTGGAG
0301 TTGCAGATAG AAGCCAAGCC AGCAGTAGGA CAGTGCACGT CTCGGTTCCT ACCACACCTA
0361 ATGAAACTCC CAGTAGCACT TCGGAGACGA AGCTAAAGTT GCTTTATGGG TATACATCGT
0421 ATGACATAAA TAACGACCAA CAGGTAAAGT CCAACAATTT ATGTAGAGTG CTTTGTAAAA
0481 GTCGCAATCG TAAACGACAG |
in silico PCR Fragment |
0001 CATTCAAAGG CAGCAGGTGT TTCTTTAATT GTCAATGCAT CTGCTGTCGC CAAGGATGCT
0061 GCGTTGTGGT TGTAAAGTGC TGTTGCTGCT TTAACTTAAA CTGCTGCAAC AGCCTTGGCT
0121 CCCGGAAGTC ATTTCCACAA CCCGCTGCAA TGCGTAAAAA AGTTGCTGAC CTCGAAGTCC
0181 TTAGAGTATC AAGGTTTGTG GCGGTTATTT TAGTGCTGGC TCGGTGGGTT ACTGCGGTAG
0241 CGACACTCCT GACAAGCTGC ATACTCCTAG ACATATTTTC CGTGCCTGGC CAGTCTGGAG
0301 TTGCAGATAG AAGCCAAGCC AGCAGTAGGA CAGTGCACGT CTCGGTTCCT ACCACACCTA
0361 ATGAAACTCC CAGTAGCACT TCGGAGACGA AGCTAAAGTT GCTTTATGGG TATACATCGT
0421 ATGACATAAA TAACGACCAA CAGGTAAAGT CCAACAATTT ATGTAGAGTG CTTTGTAAAA
0481 GTCGCAATCG TAAACGACAG |
Assemble Data |
11062R-1.IR_full 1 CATTCAAAGGCAGCAGGTGTTTCTTTAATTGTCAATGCATCTGCTGTCGCCAAGGATGCT 60
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
11062R-1.in silico 1 CATTCAAAGGCAGCAGGTGTTTCTTTAATTGTCAATGCATCTGCTGTCGCCAAGGATGCT 60
11062R-1.IR_full 61 GCGTTGTGGTTGTAAAGTGCTGTTGCTGCTTTAACTTAAACTGCTGCAACAGCCTTGGCT 120
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
11062R-1.in silico 61 GCGTTGTGGTTGTAAAGTGCTGTTGCTGCTTTAACTTAAACTGCTGCAACAGCCTTGGCT 120
11062R-1.IR_full 121 CCCGGAAGTCATTTCCACAACCCGCTGCAATGCGTAAAAAAGTTGCTGACCTCGAAGTCC 180
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
11062R-1.in silico 121 CCCGGAAGTCATTTCCACAACCCGCTGCAATGCGTAAAAAAGTTGCTGACCTCGAAGTCC 180
11062R-1.IR_full 181 TTAGAGTATCAAGGTTTGTGGCGGTTATTTTAGTGCTGGCTCGGTGGGTTACTGCGGTAG 240
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
11062R-1.in silico 181 TTAGAGTATCAAGGTTTGTGGCGGTTATTTTAGTGCTGGCTCGGTGGGTTACTGCGGTAG 240
11062R-1.IR_full 241 CGACACTCCTGACAAGCTGCATACTCCTAGACATATTTTCCGTGCCTGGCCAGTCTGGAG 300
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
11062R-1.in silico 241 CGACACTCCTGACAAGCTGCATACTCCTAGACATATTTTCCGTGCCTGGCCAGTCTGGAG 300
11062R-1.IR_full 301 TTGCAGATAGAAGCCAAGCCAGCAGTAGGACAGTGCACGTCTCGGTTCCTACCACACCTA 360
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
11062R-1.in silico 301 TTGCAGATAGAAGCCAAGCCAGCAGTAGGACAGTGCACGTCTCGGTTCCTACCACACCTA 360
11062R-1.IR_full 361 ATGAAACTCCCAGTAGCACTTCGGAGACGAAGCTAAAGTTGCTTTATGGGTATACATCGT 420
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
11062R-1.in silico 361 ATGAAACTCCCAGTAGCACTTCGGAGACGAAGCTAAAGTTGCTTTATGGGTATACATCGT 420
11062R-1.IR_full 421 ATGACATAAATAACGACCAACAGGTAAAGTCCAACAATTTATGTAGAGTGCTTTGTAAAA 480
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
11062R-1.in silico 421 ATGACATAAATAACGACCAACAGGTAAAGTCCAACAATTTATGTAGAGTGCTTTGTAAAA 480
11062R-1.IR_full 481 GTCGCAATCGTAAACGACAG 500
||||||||||||||||||||
11062R-1.in silico 481 GTCGCAATCGTAAACGACAG 500
|
Off-target information (Last Update: November 4, 2007_NCBI RefSeq Release 26) |
Off-target search result
cv : coefficient of variation
(0 mm hits / total siRNA count)
mm : mismatch
|
cv |
0mm |
1mm |
2mm |
3mm |
target transcript |
off target name |
100 |
482 |
0 |
0 |
0 |
NM_143685.2 |
CG11062-RA (activin-beta), mRNA |
0 |
0 |
3 |
5 |
4 |
NM_057894.3 |
CG5799-RA, transcript variant A (dve), mRNA |
0 |
0 |
3 |
5 |
2 |
NM_057893.3 |
CG5799-RB, transcript variant B (dve), mRNA |
0 |
0 |
1 |
4 |
4 |
NM_080097.2 |
CG6699-RA (beta'Cop), mRNA |
0 |
0 |
1 |
2 |
2 |
NM_137736.1 |
CG15666-RA (CG15666), mRNA |
0 |
0 |
1 |
1 |
1 |
NM_001015215.1 |
CG40158-PA.3 (CG40158), mRNA |
0 |
0 |
0 |
5 |
2 |
NM_136412.2 |
CG4445-RA (pgant3), mRNA |
0 |
0 |
0 |
4 |
5 |
NM_079938.3 |
CG2102-RA (cas), mRNA |
0 |
0 |
0 |
4 |
5 |
NM_140907.1 |
CG17732-RA (CG17732), mRNA |
0 |
0 |
0 |
4 |
2 |
NM_168987.1 |
CG32350-RA (CG32350), mRNA |
0 |
0 |
0 |
3 |
10 |
NM_135831.2 |
CG7578-RA, transcript variant A (sec71), mRNA |
0 |
0 |
0 |
3 |
10 |
NM_165059.1 |
CG7578-RB, transcript variant B (sec71), mRNA |
0 |
0 |
0 |
3 |
7 |
NM_080250.2 |
CG6224-RA (dbo), mRNA |
0 |
0 |
0 |
3 |
4 |
NM_136011.2 |
CG7527-RA, transcript variant A (CadN2), mRNA |
0 |
0 |
0 |
3 |
4 |
NM_001042903.1 |
CG7527-RB, transcript variant B (CadN2), mRNA |
0 |
0 |
0 |
3 |
4 |
NM_142103.1 |
CG14846-RA (CG14846), mRNA |
0 |
0 |
0 |
3 |
4 |
NM_169659.2 |
CG14869-RA, transcript variant A (CG14869), mRNA |
0 |
0 |
0 |
3 |
4 |
NM_206496.1 |
CG14869-RB, transcript variant B (CG14869), mRNA |
0 |
0 |
0 |
3 |
4 |
NM_137031.2 |
CG4840-RA (CG4840), mRNA |
0 |
0 |
0 |
3 |
4 |
NM_141914.2 |
CG3942-RA (CG3942), mRNA |
0 |
0 |
0 |
3 |
4 |
NM_079470.2 |
CG10564-RA (Ac78C), mRNA |
0 |
0 |
0 |
3 |
3 |
NM_132779.1 |
CG15028-RB, transcript variant B (CG15028), mRNA |
0 |
0 |
0 |
3 |
3 |
NM_167431.1 |
CG15028-RA, transcript variant A (CG15028), mRNA |
0 |
0 |
0 |
3 |
3 |
NM_137970.3 |
CG5411-RE, transcript variant E (Pde8), mRNA |
0 |
0 |
0 |
3 |
2 |
NM_136921.1 |
CG13162-RA (CG13162), mRNA |
0 |
0 |
0 |
3 |
2 |
NM_001043220.1 |
CG34127-RA (CG34127), mRNA |
0 |
0 |
0 |
3 |
2 |
NM_001032092.1 |
CG33649-RA, transcript variant A (CG33649), mRNA |
0 |
0 |
0 |
3 |
2 |
NM_001032091.1 |
CG33650-RA, transcript variant A (DNApol-gamma35), mRNA |
0 |
0 |
0 |
2 |
12 |
NM_132908.2 |
CG4453-RA (Nup153), mRNA |
0 |
0 |
0 |
2 |
9 |
NM_140080.1 |
CG3335-RA (CG3335), mRNA |
|
|
|